Allergen challenge and deposition of nedocromil sodium in asthma

Beth L Laube, Ta Chun Lin, Anne Valleteau, Richard N. Dalby, Fiona B. Diemer, Alkis G. Togias

Research output: Contribution to journalArticle

Abstract

We examined whether the acute protective effect of nedocromil sodium aerosol could be enhanced by increasing the deposition uniformity of the drug in the lungs of adult patients with allergic asthma. Ten patients with mild-to-moderate asthma were challenged with the same doses of allergen on two occasions in a randomized manner. Thirty minutes before these challenges, patients inhaled 4 mg nedocromil sodium, admixed with the radioisotope 99mtechnetium. Radiolabeled drug was inhaled during slow (25.4 ± 4.6 L/min) and faster (58.0 ± 7.3 L/min) inhalations from a 700 ml holding chamber. Percent changes in FEV1 at the same top dose of allergen on the two treatment visits were compared. Lung deposition fraction (LDF) and indices of distribution uniformity, quantified from gamma camera images, were also compared. Acute protection against allergen challenge was similar and complete after slow or faster inspiration of nedocromil sodium. Mean (±SD) allergen-induced changes in FEV1 were -1.05 ± 2.78% and -0.39 ± 2.80%, respectively, compared to -26.30 ± 8.49% on a screening challenge (no drug). Mean LDF was also similar on the two visits, averaging 16.4 ± 4.6% and 16.1 ± 7.2% of administered drug, respectively. Distribution of nedocromil sodium was most uniform after slow inspiration, but increased uniformity was not related to enhanced protection. Complete protection against acute bronchoconstriction induced by inhaled allergen can be obtained with 4 mg of nedocromil sodium aerosol, inhaled from a large volume holding chamber, 30 min before the exposure, and at inspiratory flow rates between ∼20-60 L/min. Protection does not appear to be enhanced by increased uniformity of drug distribution within the lungs.

Original languageEnglish (US)
Pages (from-to)415-425
Number of pages11
JournalJournal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung
Volume15
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Nedocromil
Allergens
Asthma
Lung
Pharmaceutical Preparations
Aerosols
Gamma Cameras
Bronchoconstriction
Radioisotopes
Inhalation

Keywords

  • Acute antigen response
  • Aerosol deposition
  • Asthma
  • Nedocromil sodium

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Allergen challenge and deposition of nedocromil sodium in asthma. / Laube, Beth L; Lin, Ta Chun; Valleteau, Anne; Dalby, Richard N.; Diemer, Fiona B.; Togias, Alkis G.

In: Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, Vol. 15, No. 4, 2002, p. 415-425.

Research output: Contribution to journalArticle

Laube, Beth L ; Lin, Ta Chun ; Valleteau, Anne ; Dalby, Richard N. ; Diemer, Fiona B. ; Togias, Alkis G. / Allergen challenge and deposition of nedocromil sodium in asthma. In: Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung. 2002 ; Vol. 15, No. 4. pp. 415-425.
@article{8c1ced477fdf45c89585fd087aaaffb2,
title = "Allergen challenge and deposition of nedocromil sodium in asthma",
abstract = "We examined whether the acute protective effect of nedocromil sodium aerosol could be enhanced by increasing the deposition uniformity of the drug in the lungs of adult patients with allergic asthma. Ten patients with mild-to-moderate asthma were challenged with the same doses of allergen on two occasions in a randomized manner. Thirty minutes before these challenges, patients inhaled 4 mg nedocromil sodium, admixed with the radioisotope 99mtechnetium. Radiolabeled drug was inhaled during slow (25.4 ± 4.6 L/min) and faster (58.0 ± 7.3 L/min) inhalations from a 700 ml holding chamber. Percent changes in FEV1 at the same top dose of allergen on the two treatment visits were compared. Lung deposition fraction (LDF) and indices of distribution uniformity, quantified from gamma camera images, were also compared. Acute protection against allergen challenge was similar and complete after slow or faster inspiration of nedocromil sodium. Mean (±SD) allergen-induced changes in FEV1 were -1.05 ± 2.78{\%} and -0.39 ± 2.80{\%}, respectively, compared to -26.30 ± 8.49{\%} on a screening challenge (no drug). Mean LDF was also similar on the two visits, averaging 16.4 ± 4.6{\%} and 16.1 ± 7.2{\%} of administered drug, respectively. Distribution of nedocromil sodium was most uniform after slow inspiration, but increased uniformity was not related to enhanced protection. Complete protection against acute bronchoconstriction induced by inhaled allergen can be obtained with 4 mg of nedocromil sodium aerosol, inhaled from a large volume holding chamber, 30 min before the exposure, and at inspiratory flow rates between ∼20-60 L/min. Protection does not appear to be enhanced by increased uniformity of drug distribution within the lungs.",
keywords = "Acute antigen response, Aerosol deposition, Asthma, Nedocromil sodium",
author = "Laube, {Beth L} and Lin, {Ta Chun} and Anne Valleteau and Dalby, {Richard N.} and Diemer, {Fiona B.} and Togias, {Alkis G.}",
year = "2002",
doi = "10.1089/08942680260473498",
language = "English (US)",
volume = "15",
pages = "415--425",
journal = "Journal of Aerosol Medicine and Pulmonary Drug Delivery",
issn = "1941-2711",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Allergen challenge and deposition of nedocromil sodium in asthma

AU - Laube, Beth L

AU - Lin, Ta Chun

AU - Valleteau, Anne

AU - Dalby, Richard N.

AU - Diemer, Fiona B.

AU - Togias, Alkis G.

PY - 2002

Y1 - 2002

N2 - We examined whether the acute protective effect of nedocromil sodium aerosol could be enhanced by increasing the deposition uniformity of the drug in the lungs of adult patients with allergic asthma. Ten patients with mild-to-moderate asthma were challenged with the same doses of allergen on two occasions in a randomized manner. Thirty minutes before these challenges, patients inhaled 4 mg nedocromil sodium, admixed with the radioisotope 99mtechnetium. Radiolabeled drug was inhaled during slow (25.4 ± 4.6 L/min) and faster (58.0 ± 7.3 L/min) inhalations from a 700 ml holding chamber. Percent changes in FEV1 at the same top dose of allergen on the two treatment visits were compared. Lung deposition fraction (LDF) and indices of distribution uniformity, quantified from gamma camera images, were also compared. Acute protection against allergen challenge was similar and complete after slow or faster inspiration of nedocromil sodium. Mean (±SD) allergen-induced changes in FEV1 were -1.05 ± 2.78% and -0.39 ± 2.80%, respectively, compared to -26.30 ± 8.49% on a screening challenge (no drug). Mean LDF was also similar on the two visits, averaging 16.4 ± 4.6% and 16.1 ± 7.2% of administered drug, respectively. Distribution of nedocromil sodium was most uniform after slow inspiration, but increased uniformity was not related to enhanced protection. Complete protection against acute bronchoconstriction induced by inhaled allergen can be obtained with 4 mg of nedocromil sodium aerosol, inhaled from a large volume holding chamber, 30 min before the exposure, and at inspiratory flow rates between ∼20-60 L/min. Protection does not appear to be enhanced by increased uniformity of drug distribution within the lungs.

AB - We examined whether the acute protective effect of nedocromil sodium aerosol could be enhanced by increasing the deposition uniformity of the drug in the lungs of adult patients with allergic asthma. Ten patients with mild-to-moderate asthma were challenged with the same doses of allergen on two occasions in a randomized manner. Thirty minutes before these challenges, patients inhaled 4 mg nedocromil sodium, admixed with the radioisotope 99mtechnetium. Radiolabeled drug was inhaled during slow (25.4 ± 4.6 L/min) and faster (58.0 ± 7.3 L/min) inhalations from a 700 ml holding chamber. Percent changes in FEV1 at the same top dose of allergen on the two treatment visits were compared. Lung deposition fraction (LDF) and indices of distribution uniformity, quantified from gamma camera images, were also compared. Acute protection against allergen challenge was similar and complete after slow or faster inspiration of nedocromil sodium. Mean (±SD) allergen-induced changes in FEV1 were -1.05 ± 2.78% and -0.39 ± 2.80%, respectively, compared to -26.30 ± 8.49% on a screening challenge (no drug). Mean LDF was also similar on the two visits, averaging 16.4 ± 4.6% and 16.1 ± 7.2% of administered drug, respectively. Distribution of nedocromil sodium was most uniform after slow inspiration, but increased uniformity was not related to enhanced protection. Complete protection against acute bronchoconstriction induced by inhaled allergen can be obtained with 4 mg of nedocromil sodium aerosol, inhaled from a large volume holding chamber, 30 min before the exposure, and at inspiratory flow rates between ∼20-60 L/min. Protection does not appear to be enhanced by increased uniformity of drug distribution within the lungs.

KW - Acute antigen response

KW - Aerosol deposition

KW - Asthma

KW - Nedocromil sodium

UR - http://www.scopus.com/inward/record.url?scp=0036964520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036964520&partnerID=8YFLogxK

U2 - 10.1089/08942680260473498

DO - 10.1089/08942680260473498

M3 - Article

C2 - 12581508

AN - SCOPUS:0036964520

VL - 15

SP - 415

EP - 425

JO - Journal of Aerosol Medicine and Pulmonary Drug Delivery

JF - Journal of Aerosol Medicine and Pulmonary Drug Delivery

SN - 1941-2711

IS - 4

ER -